Abstract
In the management of patients with differentiated thyroid carcinoma, direct comparison of the presence of scintigraphic stunning after a diagnostic dose of I with subsequent successful ablation has not been evaluated.
| Original language | English |
|---|---|
| Pages (from-to) | 793-797 |
| Number of pages | 5 |
| Journal | Nuclear Medicine Communications |
| Volume | 25 |
| Issue number | 8 |
| DOIs | |
| State | Published - 08 2004 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Radioiodine ablation
- Thyroid cancer
- Thyroid stunning
Fingerprint
Dive into the research topics of 'Influence of i diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent stunning and the impairment of successful ablation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver